Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Dec 19, 2017. Jeff Shuren.

Executive Summary

Check out what US FDA device-center director Jeff Shuren had to say about an alternative 510(k) pathway the center is developing that does not depend on a technology comparison to a predicate device.

"You can really say, this isn't your grandmother's device and it isn't your grandmother's standard." – Jeff Shuren, director, US FDA Center for Devices and Radiological Health

> Find out more: A No-Predicate 510(k) Future? Pending US FDA Policy Might Forge A Path

Click here for a free trial of Medtech Insight


Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT121937

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel